The Economic Times Healthcare and Biotech News This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Centre bans anti-cold fixed drug combination for under-four children
In a letter dated December 18, the drug regulator said that FDC (fixed-dose combination) chlorpheniramine maleate and phenylephrine should not be given to children aged under four. It also said that the firms manufacturing it should carry a warning in this regard on the medicine label and package insert. The decision was taken after a review by a sub-committee of experts. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 20, 2023 Category: Pharmaceuticals Source Type: news

Govt bans anti-cold fixed drug combination for under-four children
The matter was deliberated in the Subject Expert Committee (SEC- Pulmonary) meeting held on June 6. "The committee recommended that the FDC should not be used in children below four years of age and accordingly the firms should mention warnings in this regard on label and package insert. The recommendation of the SEC has been considered by this office," the letter stated. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 20, 2023 Category: Pharmaceuticals Source Type: news

JB Pharma acquires trademark licenses, distribution rights of Novartis eye care portfolio in India for Rs 1089 crore
JB will pay Rs 964 crore for the portfolio licensing agreement with Novartis Innovative Therapies AG which the company said is "perpetual in nature" to become effective from January 2027. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 20, 2023 Category: Pharmaceuticals Source Type: news

API maker Fleming Laboratories raises Rs 110 cr from PE fund InvAscent
Fleming is a backward integrated API manufacturer with global leadership in select muscle relaxant, anti-arthritis, and antihistamine APIs with two regulatory-approved manufacturing units. The company sells to customers in over 65 countries across Latin America, Europe, Asia, and MENA. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 19, 2023 Category: Pharmaceuticals Source Type: news

JB Pharma inks Rs 1,089 cr pacts with Novartis for select ophthalmology brands
The board of directors at its meeting held on December 19, 2023 approved the execution of a trade mark licence agreement with Novartis Innovative Therapies AG, which is perpetual in nature for the Indian market, for a portfolio of select ophthalmology brands which will be effective in January 2027, JB Pharma said in a regulatory filing. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 19, 2023 Category: Pharmaceuticals Source Type: news

ET Awards for Corporate Excellence: Rx Meerut: Mankind Pharma's bottom-up journey to the leader board
The company has for the last five years been ranked number one in the number of prescriptions. Manforce condoms, oral contraceptives Prega News and Unwanted 72, Gas-o-Fast (antacid), AcneStar (skin brand) and multivitamin HealthOK News are among the top-selling consumer health brands in India. In May, Mankind had a successful IPO, listing at a 20% premium. The stock has since risen nearly 30%. Mankind had revenue of ₹8,749 crore and profit of ₹1,310 crore in FY23. Domestic revenue accounted for 97% of the total. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 18, 2023 Category: Pharmaceuticals Source Type: news

Rx Meerut: A bottom-up journey to the pharma leader board
The company has for the last five years been ranked number one in the number of prescriptions. Manforce condoms, oral contraceptives Prega News and Unwanted 72, Gas-o-Fast (antacid), AcneStar (skin brand) and multivitamin HealthOK News are among the top-selling consumer health brands in India. In May, Mankind had a successful IPO, listing at a 20% premium. The stock has since risen nearly 30%. Mankind had revenue of ₹8,749 crore and profit of ₹1,310 crore in FY23. Domestic revenue accounted for 97% of the total. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 18, 2023 Category: Pharmaceuticals Source Type: news

Biocon Biologics completes integration of Viatris' biosimilar business in 120 countries
The company said over 10 emerging markets along with Japan, Australia and New Zealand have transitioned in this final phase of the integration of the biosimilars business acquired from Viatris. With the completion of this significant milestone, Biocon Biologics is now a fully integrated ‘lab to market’ biosimilars company committed to serving millions of patients across the globe. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 18, 2023 Category: Pharmaceuticals Source Type: news

Sun Pharma, Lupin recall drugs in US market: USFDA
Sun Pharmaceutical is recalling the affected lot that was produced at the drugmaker's Dadra-based facility. The company is recalling the lot due to "failed impurities/degradation specifications", the USFDA stated. USFDA stated that Mumbai-based Lupin is also recalling an unspecified number of penicillamine tablets in the US. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 17, 2023 Category: Pharmaceuticals Source Type: news

Haryana-based pharma firm MITS plans to expand across India, abroad
As part of expansion plans, Bhatia announced the appointment of 5 new directors of MITS Group and made Shilpa Chandel as its CEO. Chandel has been serving the company for the past eight years. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 16, 2023 Category: Pharmaceuticals Source Type: news

Zydus Lifesciences gets USFDA nod to sell generic anti-epileptic medication
Zydus Lifesciences has received approval from the US FDA to market Lacosamide Tablets, a generic anti-epileptic medication used to treat partial-onset seizures and primary generalized tonic-clonic seizures. The product will be manufactured at the company's manufacturing facility in Ahmedabad. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 16, 2023 Category: Pharmaceuticals Source Type: news

Bill seeking to regulate drugs, medical gear may be tabled in Parliament
The Drugs, Medical Devices, and Cosmetics Bill, which aims to replace the 83-year-old Drugs and Cosmetics Act, may be introduced in the ongoing session of the Indian Parliament. The bill is designed to regulate the import, manufacture, distribution, and sale of drugs, medical devices, and cosmetics. It aims to ensure the quality, safety, efficacy, and performance of these products, including clinical trials for new drugs and investigations for medical devices (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 15, 2023 Category: Pharmaceuticals Source Type: news

India's veg diet may be key to fight Alzheimer's: Study
This study also outlines several foods that are protective against Alzheimer's disease, such as green leafy vegetables, colourful fruits and vegetables, legumes (like beans), nuts, omega-3 fatty acids, and whole grains. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 15, 2023 Category: Pharmaceuticals Source Type: news

Zydus gets USFDA nod for antiviral drug used in HIV treatment
Zydus Lifesciences obtained final clearance from the USFDA for Darunavir Tablets, an antiviral medication used in treating HIV-1 infection. Darunavir, a protease inhibitor, restricts HIV-1 multiplication and is prescribed for adults and pediatric patients over three years old. Co-administration with Ritonavir and other antiretroviral agents is necessary. Manufactured in Ahmedabad, Gujarat, the medication holds significant market potential, recording USD 275 million in annual US sales. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 15, 2023 Category: Pharmaceuticals Source Type: news

Biocon denies plans to sell $1.5 billion generic API business
Biocon API business: Biocon has refuted claims of considering the sale of its generic active pharmaceutical ingredient (API) business, valued at $1.5 billion, to alleviate its debt burden. A company spokesperson clarified they were not assessing divestment options or seeking advice from bankers, countering an ET report based on insights from familiar sources. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - December 15, 2023 Category: Pharmaceuticals Source Type: news